GAD THOMAS (President and Chairman) sold 30.1% of their position (70K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $841.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/11/2024ACC: 0001104659-24-070532
DirectorOfficer· President and Chairman
Since Sep 2018
-70K
Net shares
Net seller
$841.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
70K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−35K
Price / share
$12.03
Trade value
$421.05K
% of position
15.0%
6/10/2024
232.68K→197.68K
Common Stock
Indirect
Shares
−35K
Price / share
$12.00
Trade value
$420K
% of position
17.7%
6/11/2024
197.68K→162.68K
Total
Net shares
−70K
Net value
-$841.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/10/2024 | S · Sale | −35K | $12.03 | $421.05K | 15.0% | 232.68K | 197.68K |
| Common Stock Indirect | 6/11/2024 | S · Sale | −35K | $12.00 | $420K | 17.7% | 197.68K | 162.68K |
| Total | −70K | -$841.05K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned158.70K
Common Stock
IndirectShares owned60K
Total
158.70K direct·60K indirect218.70K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 158.70K | Direct |
| Common Stock | 60K | Indirect |
| Total | 218.70K | 158.70K direct·60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported